GSK aims for 1 billion doses with COVID vaccine booster plan

Britain's GlaxoSmithKline laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters, or adjuvants, next year as the race to develop and produce a successful solution to the coronavirus crisis heats up.